Value of baseline levels in assessing tryptase release

Inflammation Research

Volumn 49, Issue SUPPL. 1, 2000, Pages

  Lynch, J P ^a   Renz, C L ^a   Laroche, D ^b   Moss, J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; TRYPTASE;

ANAPHYLAXIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME RELEASE; HISTAMINE BLOOD LEVEL; HUMAN; IMMUNITY;

EID: 0034102912     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00000165     Document Type: Conference Paper

References (5)

1. Gueant JL, Aimone-Gastin I, Namour F, Laroche D, Bellou A, Laxenaire MC. Diagnosis and pathogenesis of the anaphylactic and anaphylactoid reactions to anaesthetics. Clin Exp Allergy 1998; 28 (Suppl 4): 65-70.
2. He S, Gaça MD, Walls AF. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase. J Pharm Exp Ther 1998; 286: 289-97.
3. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80: 26-9.
4. Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R, Moss J. Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 1998; 89: 620-5.
5. Laroche D, Vergnaud M-C, Sillard B, Soufarapis H, Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesthesiology 1991; 75: 945-9.